MedPath
HSA Approval

BECAME TABLET

SIN07964P

BECAME TABLET

BECAME TABLET

December 15, 1994

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

R01BA52

pseudoephedrine, combinations

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y S P INDUSTRIES (M) SDN BHD

Active Ingredients

PSEUDOEPHEDRINE HCl

60 mg

Pseudoephedrine

CARBINOXAMINE MALEATE

4 mg

Carbinoxamine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BECAME TABLET - HSA Approval | MedPath